Skip to main content

Technology

By Andrea Fox | 05:38 pm | January 16, 2026
Amy Tucker of Advocate Health's Sanger Heart & Vascular Institute explains what it takes to move to a scalable platform that improves clinical administration and patient care.
By Jessica Hagen | 12:59 pm | January 16, 2026
Outside the JPM Healthcare Conference, Thomas Clozel, cofounder and CEO of Owkin, sat down with MobiHealthNews to discuss how the company is using AI to find causality in disease.
By HIMSS TV | 10:43 am | January 16, 2026
Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.
By Jessica Hagen | 08:00 am | January 16, 2026
Silicon Valley Bank head of healthcare and life sciences says the bank's strategy has remained the same since its collapse in 2023.
By Jessica Hagen | 12:16 pm | January 15, 2026
The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders and engineers.
By Jessica Hagen | 10:26 am | January 15, 2026
The CEO of Transcarent sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss AI's place in healthcare and its use in expanding access.
By Nathan Eddy | 11:04 am | January 14, 2026
The partnership combines Abridge's conversational AI platform with Availity’'s FHIR-native Intelligent Utilization Management technology.
By Jessica Hagen | 10:00 am | January 13, 2026
Julia Zarb, principal and founder of Blue x Blue, discusses her upcoming HIMSS26 talk, exploring 'human in the loop' AI practices and workflows that support human decision-making.
By Andrea Fox | 09:00 am | January 13, 2026
By searching and cross-referencing all electronic health record data, large language models are helping to provide leading-edge oncology care to more patients while freeing up nurses' time, says Dr. Aaron Gerds at the Cleveland Clinic’s Cancer Institute.
By Nathan Eddy | 08:00 am | January 13, 2026
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers of transplant rejection and patient response variability.